tradingkey.logo


tradingkey.logo


Bone Biologics Corp

BBLGW

詳现チャヌトを衚瀺
12.550USD
-6.300-33.42%
終倀 02/06, 16:00ET15分遅れの株䟡
0.00時䟡総額
--盎近12ヶ月PER


Bone Biologics Corp

12.550
-6.300-33.42%
Intraday
1m
30m
1h
D
W
M
D

本日

-33.42%

5日間

-20.32%

1ヶ月

-14.63%

6ヶ月

+51.20%

幎初来

-61.38%

1幎間

-86.05%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

デヌタが䞍十分なため、株匏スコアは利甚できたせん。

Bone Biologics Corp ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Bone Biologics Corpの䌁業情報

Bone Biologics Corporation is a developer of orthobiologic products for spine fusion markets. It is focusing development efforts for its bone graft substitute product on bone regeneration in spinal fusion procedures, while additionally having rights to trauma and osteoporosis applications. It is a medical device company that is focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with demineralized bone matrix (DBM), is an osteopromotive recombinant protein that provides target specific control over bone regeneration. Its platform technology is its NELL-1, a proprietary skeletal specific growth factor which is a bone void filler. NELL-1 provides regulation over skeletal tissue formation and stem cell differentiation during bone regeneration. The DBM Demineralized Bone Putty provided as part of the convenience kit with NELL-1/DBM is a Class II device. DBM Putty is a matrix composed of processed human cortical bone.
䌁業コヌドBBLGW
䌁業名Bone Biologics Corp
最高経営責任者「CEO」Mr. Jeffrey Frelick
りェブサむトhttps://www.bonebiologics.com/
KeyAI
î™